Typical project outcomes:


Our technology platform:

  • FBLD: Fragment-based lead discovery
  • CFL: A proprietary next generation 3D fragment library
  • Syntheverse™: Improved access to currently synthesizable compounds

BioBlocks chemists are often inventors on our clients' patents: 

Issued Patents:

US 9040714
US 8912203
US 8680099
US 8674095
US 8372970

Recent Applications:

WO 2015050472
WO 2015020556
WO 2014153055
WO 2014018570